NFKB1 and hereditary elliptocytosis: Previous studies have shown that HE decreases the expression of apoptotic markers and inflammatory cytokines through modulating the MAPK, NFκB, and PI3K/AKT pathways (Lu et al., 2015; Kim et al., 2017) in other disease models.